|Up a level|
Blesch, A. and Bosserhoff, Anja-Katrin and Apfel, R. and Behl, C. and Hessdoerfer, B. and Schmitt, A. and Jachimczak, P. and Lottspeich, F. and Buettner, R. and Bogdahn, Ulrich (1994) Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Research 54 (21), pp. 5695-5701.
Behl, C. and Winkler, J. and Bogdahn, U. and Meixensberger, J. and Schlingensiepen, K. H. and Brysch, W. (1993) Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules. Neurosurgery 33 (4), pp. 679-684.
Behl, C. and Bogdahn, U. and Winkler, J. and Apfel, R. and Brysch, W. and Schlingensiepen, K. H. (1993) Autoinduction of platelet derived growth factor (PDGF) A-chain mRNA expression in a human malignant melanoma cell line and growth inhibitory effects of PDGF-A-chain mRNA-specific antisense molecules. Biochemical and biophysical research communications 193 (2), pp. 744-751.
Jachimczak, P. and Bogdahn, U. and Schneider, J. and Behl, C. and Meixensberger, J. and Apfel, R. and Dörries, R. and Schlingensiepen, K. H. and Brysch, W. (1993) The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. Journal of neurosurgery 78 (6), pp. 944-951.
Bogdahn, U. and Drenkard, D. and Lutz, M. and Apfel, R. and Behl, C. (1991) In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours. Journal of cancer research and clinical oncology 117 (Suppl ), S157-163.
Weilbach, F. X. and Bogdahn, U. and Poot, M. and Apfel, R. and Behl, C. and Drenkard, D. and Martin, R. and Hoehn, H. (1990) Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment. Cancer research 50 (21), pp. 6981-6986.
Bogdahn, U. and Apfel, R. and Hahn, M. and Gerlach, M. and Behl, C. and Hoppe, J. and Martin, R. (1989) Autocrine tumor cell growth-inhibiting activities from human malignant melanoma. Cancer research 49 (19), pp. 5358-5363.